Genitourinary Cancer
Latest News
After doc uproar, NCCN reverses prostate cancer guidance
This advice aligns closely with the group’s initial recommendation, published over a decade ago.
Latest News
Shock, disbelief as NCCN changes prostate cancer guidance
“To suggest for a millisecond that active surveillance isn’t the preferred method for low-risk men is bizarre thinking ... Is this 1980?”
News
Urine test for prostate cancer signals amount of aggressive tumor
“PUR will also be useful for monitoring disease in men that do not currently require treatment and flag up the emergence” of aggressive disease....
News
Severe COVID two times higher for cancer patients
News
Overall survival for metastatic urothelial carcinoma approaching 2 years
Metastatic urothelial carcinoma is still a hard-to-treat condition with a 12- to 15-month survival for metastatic disease that is treated. In a...
News
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomes
Observational study finds that antibiotics and glucocorticoids at 10 mg daily when given within 1 month before or after immune checkpoint...
News
Gut bacteria may fuel prostate cancer treatment resistance
The findings may suggest new therapeutic targets: the microbes living in the gut.
Conference Coverage
Many patients, doctors unaware of advancements in cancer care
“These patients must be spared the traumatic effects of being handed a death sentence that no longer reflects the current reality,” said Dr....
Conference Coverage
Most community-based oncologists skip biomarker testing
Survey shows that 48% of community clinicians use biomarker testing to guide treatment decisions, compared with 73% of academic clinicians.
News
Immunotherapy for cancer patients with poor PS needs a rethink
Patients should not receive immunotherapy just to reduce risk of side effects, doctor says.
